Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.75 USD
Change Today +0.0541 / 7.77%
Volume 204.8K
SPHS On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Frankfurt
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

sophiris bio inc (SPHS) Snapshot

Open
$0.73
Previous Close
$0.70
Day High
$0.76
Day Low
$0.69
52 Week High
05/19/14 - $3.60
52 Week Low
02/4/15 - $0.42
Market Cap
12.6M
Average Volume 10 Days
316.0K
EPS TTM
$-1.85
Shares Outstanding
16.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SOPHIRIS BIO INC (SPHS)

Related News

No related news articles were found.

sophiris bio inc (SPHS) Related Businessweek News

No Related Businessweek News Found

sophiris bio inc (SPHS) Details

Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company’s primary product candidate is PRX302, which is in Phase III clinical trial for treatment for the symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. It has a strategic relationship with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of PRX302 and other products for the treatment of the symptoms of BPH, prostate cancer, prostatitis, or other diseases of the prostate; and license agreement with UVIC Industry Partnerships Inc. and The Johns Hopkins University with respect to the use of PRX302 for the development of therapeutics for the symptoms of BPH, prostate cancer, and other non-cancer diseases and conditions of the prostate. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. Sophiris Bio, Inc. was founded in 2002 and is based in La Jolla, California.

9 Employees
Last Reported Date: 03/10/15

sophiris bio inc (SPHS) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $437.8K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $293.4K
Chief Operating Officer and Head of Research ...
Total Annual Compensation: $339.9K
Compensation as of Fiscal Year 2013.

sophiris bio inc (SPHS) Key Developments

Sophiris Bio, Inc. Announces Unaudited Consolidated Cash Flow Results for the Year Ended December 31, 2014

Sophiris Bio, Inc. announced unaudited consolidated cash flow results for the year ended December 31, 2014. For the year, the company’s net cash used in operating activities was $26,230,000 against $13,206,000 a year ago. Purchases of property and equipment were $9,000 against $3,000 a year ago.

Sophiris Bio, Inc. Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-04-2015 03:00 PM

Sophiris Bio, Inc. Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-04-2015 03:00 PM. Venue: Sheraton Centre Toronto Hotel (Corner of York and Queen St. West), Toronto, Ontario, M5H 3M9, Canada.

Sophiris Bio, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 02:20 PM

Sophiris Bio, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 02:20 PM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: Randall E. Woods, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPHS:US $0.75 USD +0.0541

SPHS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SPHS.
View Industry Companies
 

Industry Analysis

SPHS

Industry Average

Valuation SPHS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOPHIRIS BIO INC, please visit www.sophirisbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.